DMAC
DiaMedica Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.75
+2.90%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-97.9%
Return on equity
-83.4%
Return on assets
-100.9%
Return on invested capital
0.00x
Asset turnover
-$31.6M
Cash from operations
$0.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026